Matthew T Newman

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Myasthenia Gravis

Top Venues

Cancer reports (Hoboken, N.J.)

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew T Newman, Mihir Bikhchandani
A Fatal Case of Immune Checkpoint Inhibitor-Mediated Myasthenia Gravis, Myositis, and Cardiomyopathy Overlap Syndrome in Urothelial Carcinoma. Cancer reports (Hoboken, N.J.) 7 (7) (2024)
Matthew T Newman, Mihir Bikhchandani
A Fatal Case of Immune Checkpoint Inhibitor-Mediated Myasthenia Gravis, Myositis, and Cardiomyopathy Overlap Syndrome in Urothelial Carcinoma. Cancer reports (Hoboken, N.J.) 7 (7) (2024)
Kyle A Romine, Kevin MacPherson, Hyun-Jun Cho, Yoko Kosaka, Patrick A Flynn, Kaelan H Byrd, Jesse L Coy, Matthew T Newman, Ravina Pandita, Christopher P Loo, Jaime Scott, Andrew C Adey, Evan F Lind
BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8 + T cells. Leukemia (2023)
Kyle A Romine, Kevin MacPherson, Hyun-Jun Cho, Yoko Kosaka, Patrick A Flynn, Kaelan H Byrd, Jesse L Coy, Matthew T Newman, Ravina Pandita, Christopher P Loo, Jaime Scott, Andrew C Adey, Evan F Lind
BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8 + T cells. Leukemia 37 (3) (2023)
Kyle A Romine, Kevin MacPherson, Hyun-Jun Cho, Yoko Kosaka, Patrick A Flynn, Kaelan H Byrd, Jesse L Coy, Matthew T Newman, Ravina Pandita, Christopher P Loo, Jaime Scott, Andrew C Adey, Evan F Lind
BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8 + T cells. Leukemia 37 (3) (2023)
Kyle A Romine, Kevin MacPherson, Hyun-Jun Cho, Yoko Kosaka, Patrick A Flynn, Kaelan H Byrd, Jesse L Coy, Matthew T Newman, Ravina Pandita, Christopher P Loo, Jaime Scott, Andrew C Adey, Evan F Lind
BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8 + T cells. Leukemia 37 (3) (2023)
Kyle A Romine, Kevin MacPherson, Hyun-Jun Cho, Yoko Kosaka, Patrick A Flynn, Kaelan H Byrd, Jesse L Coy, Matthew T Newman, Ravina Pandita, Christopher P Loo, Jaime Scott, Andrew C Adey, Evan F Lind
BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8 + T cells. Leukemia 37 (3) (2023)
Kyle A Romine, Kevin MacPherson, Hyun-Jun Cho, Yoko Kosaka, Patrick A Flynn, Kaelan H Byrd, Jesse L Coy, Matthew T Newman, Ravina Pandita, Christopher P Loo, Jaime Scott, Andrew C Adey, Evan F Lind
BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8 + T cells. Leukemia 37 (3) (2023)